<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Smiths &amp; Founders (India) Ltd. (SMFIL) — Tipsheet</title>
    <link>https://tipsheet.markets/company/smfil/</link>
    <atom:link href="https://tipsheet.markets/company/smfil/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Smiths &amp; Founders (India) Ltd. (SMFIL), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Tue, 28 Jul 2026 14:38:36 GMT</lastBuildDate>
    <item>
      <title>Smiths &amp; Founders signs merger with SKF Elixer — 17x its size</title>
      <link>https://tipsheet.markets/smfil-smiths-founders-signs-merger-with-skf-elixer-17x-its-size-109351/</link>
      <guid isPermaLink="true">https://tipsheet.markets/smfil-smiths-founders-signs-merger-with-skf-elixer-17x-its-size-109351/</guid>
      <pubDate>Wed, 17 Jun 2026 17:45:46 GMT</pubDate>
      <description>A ₹93 cr nano-cap just agreed to absorb a ₹235 cr revenue firm. No share exchange ratio disclosed; regulatory approvals remain.</description>
      <content:encoded><![CDATA[<p><em>A ₹93 cr nano-cap just agreed to absorb a ₹235 cr revenue firm. No share exchange ratio disclosed; regulatory approvals remain.</em></p>
<h3>What’s new</h3><ul><li>Smiths &amp; Founders signed a merger agreement to absorb SKF Elixer India, a company with ₹235.45 cr turnover, roughly 17 times its own.</li><li>No cash or share exchange ratio has been disclosed; terms are still being finalised.</li><li>The deal is subject to regulatory approvals, shareholder consent, and other conditions.</li></ul>
<h3>Why it matters</h3><p>For a nano-cap with ₹14 cr turnover and a ₹93 cr market cap, absorbing a ₹235 cr revenue entity is a dramatic scale-up, if it closes. But the lack of a share exchange ratio means existing shareholders have no idea how much dilution they face. Execution risk on a deal this size is enormous.</p>
<h3>What we’re watching</h3><ul><li>The share exchange ratio — the single most important number for existing shareholders.</li><li>Regulatory and shareholder approvals — any delay or denial kills the deal.</li><li>How Smiths &amp; Founders plans to finance integration given its tiny balance sheet.</li></ul>
<h3>The full read</h3><p>Smiths &amp; Founders (India) Ltd., a <strong>₹93 cr</strong> market-cap forgings company with trailing revenue of just <strong>₹13.98 cr</strong>, has signed a merger agreement to absorb SKF Elixer India Private Limited, a company with <strong>₹235.45 cr</strong> in turnover and <strong>₹15.45 cr</strong> paid-up capital. That is roughly <strong>17 times</strong> its own revenue. The deal is a signed agreement now, not just a board exploration, which escalates its probability. But the headline number is not the size gap; it is the blank space where the share exchange ratio should be. Existing shareholders have no idea what their stake in the combined entity will be. For a nano-cap with a P/E of <strong>68x</strong> and an ROE of just <strong>5.3%</strong>, this deal is either a major scale-up or a slow-motion dilution event. The next filing on terms will decide which.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=513418&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=SMFIL">NSE</a></p>]]></content:encoded>
      <category>M&amp;A</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Smiths &amp; Founders explores merger with SKF Elixer India</title>
      <link>https://tipsheet.markets/smfil-smiths-founders-explores-merger-with-skf-elixer-india-107272/</link>
      <guid isPermaLink="true">https://tipsheet.markets/smfil-smiths-founders-explores-merger-with-skf-elixer-india-107272/</guid>
      <pubDate>Wed, 10 Jun 2026 15:18:30 GMT</pubDate>
      <description>A nano-cap with a ₹80 cr market cap has begun the process of combining with a private company. No financial terms have been disclosed.</description>
      <content:encoded><![CDATA[<p><em>A nano-cap with a ₹80 cr market cap has begun the process of combining with a private company. No financial terms have been disclosed.</em></p>
<h3>What’s new</h3><ul><li>Smiths &amp; Founders' board approved a proposal to explore merging with SKF Elixer India Private Ltd.</li><li>The plan is subject to due diligence, valuation, and a full regulatory approval chain including the NCLT.</li><li>The MD has been delegated authority to appoint intermediaries and proceed; no timeline or deal size was given.</li></ul>
<h3>Why it matters</h3><p>This is a material event for a nano-cap because it is the first step in a process that could radically reshape its balance sheet. The company's entire market value is just ₹80 crore, so even a modest acquisition via merger would be a leap in scale. The lack of any financial detail or timeline, however, means this remains a preliminary exploration, not a committed transaction.</p>
<h3>What we’re watching</h3><ul><li>The outcome of the initial due diligence and valuation exercise.</li><li>Any disclosure on the relative size of the two companies and the proposed swap ratio.</li><li>Whether the NCLT process begins, signaling a serious intent to close.</li></ul>
<h3>The full read</h3><p>Smiths &amp; Founders, a company with a market value of <strong>₹80 crore</strong>, told the exchanges its board has greenlit the exploration of a merger with the private firm SKF Elixer India. The move is preliminary, requiring a gauntlet of steps from due diligence to NCLT approval. The board has already delegated authority to the MD to hire intermediaries and move the process along. For a nano-cap, the significance is the potential scale change. A merger combines the two entities, which means Smiths &amp; Founders' size could change dramatically once terms are set. The terms themselves are unknown. No valuation, no swap ratio, and no timeline have been disclosed. The next concrete step is the completion of due diligence and valuation, which will determine if the deal has a basis to proceed to regulators and shareholders.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=513418&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=SMFIL">NSE</a></p>]]></content:encoded>
      <category>M&amp;A</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>